APO Research
Talk to an analyst

APO RESEARCH · REPORT

Viral Vectors and Plasmid DNA Manufacturing

The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases.

Selected research

Industry Growth & Trends

Global Viral Vectors and Plasmid DNA Manufacturing Industry Growth and Trends Forecast to 2032

21 December 2025112 pages

Choose your research edition.

Industry ResearchViral Vectors and Plasmid DNA Manufacturing Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Viral Vectors and Plasmid DNA Manufacturing Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Viral Vectors and Plasmid DNA Manufacturing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Viral Vectors and Plasmid DNA Manufacturing Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Viral Vectors and Plasmid DNA Manufacturing Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases.

According to APO Research, the global Viral Vectors and Plasmid DNA Manufacturing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Viral Vectors and Plasmid DNA Manufacturing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Viral Vectors and Plasmid DNA Manufacturing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Viral Vectors and Plasmid DNA Manufacturing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Viral Vectors and Plasmid DNA Manufacturing.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Viral Vectors and Plasmid DNA Manufacturing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Viral Vectors and Plasmid DNA Manufacturing Market by Company

BioReliance

Cobra Biologics

Oxford BioMedica

UniQure

FinVector

MolMed

MassBiologics

Richter-Helm

FUJIFILM Diosynth Biotechnologies

Lonza

Aldevron

Eurogentec

Cell and Gene Therapy Catapult

Biovian

Thermo Fisher Scientific (Brammer Bio)

VGXI

PlasmidFactory

Viral Vectors and Plasmid DNA Manufacturing Segment by Type

Plasmid DNA

Viral Vectors

Viral Vectors and Plasmid DNA Manufacturing Segment by Application

Cancers

Inherited Disorders

Viral Infections

Others

Viral Vectors and Plasmid DNA Manufacturing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Viral Vectors and Plasmid DNA Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Viral Vectors and Plasmid DNA Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Viral Vectors and Plasmid DNA Manufacturing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Viral Vectors and Plasmid DNA Manufacturing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Viral Vectors and Plasmid DNA Manufacturing Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2021-2026) Table 4. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2027-2032) Table 6. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Type (2021-2026) Table 9. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Share Forecasted by Type (2027-2032) Table 11. North America Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Application (2021-2026) Table 24. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Share Forecasted by Application (2027-2032) Table 26. North America Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Viral Vectors and Plasmid DNA Manufacturing Industry Trends Table 37. Viral Vectors and Plasmid DNA Manufacturing Industry Drivers Table 38. Viral Vectors and Plasmid DNA Manufacturing Industry Opportunities and Challenges Table 39. Viral Vectors and Plasmid DNA Manufacturing Industry Restraints Table 40. Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Company (2021-2026) Table 42. Global Viral Vectors and Plasmid DNA Manufacturing Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Viral Vectors and Plasmid DNA Manufacturing Key Company Headquarters & Area Served Table 44. Global Viral Vectors and Plasmid DNA Manufacturing Company, Product Type & Application Table 45. Global Viral Vectors and Plasmid DNA Manufacturing Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Viral Vectors and Plasmid DNA Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. BioReliance Company Information Table 49. BioReliance Business Overview Table 50. BioReliance Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. BioReliance Viral Vectors and Plasmid DNA Manufacturing Product Portfolio Table 52. BioReliance Recent Development Table 53. Cobra Biologics Company Information Table 54. Cobra Biologics Business Overview Table 55. Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Product Portfolio Table 57. Cobra Biologics Recent Development Table 58. Oxford BioMedica Company Information Table 59. Oxford BioMedica Business Overview Table 60. Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Product Portfolio Table 62. Oxford BioMedica Recent Development Table 63. UniQure Company Information Table 64. UniQure Business Overview Table 65. UniQure Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. UniQure Viral Vectors and Plasmid DNA Manufacturing Product Portfolio Table 67. UniQure Recent Development Table 68. FinVector Company Information Table 69. FinVector Business Overview Table 70. FinVector Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. FinVector Viral Vectors and Plasmid DNA Manufacturing Product Portfolio Table 72. FinVector Recent Development Table 73. MolMed Company Information Table 74. MolMed Business Overview Table 75. MolMed Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. MolMed Viral Vectors and Plasmid DNA Manufacturing Product Portfolio Table 77. MolMed Recent Development Table 78. MassBiologics Company Information Table 79. MassBiologics Business Overview Table 80. MassBiologics Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. MassBiologics Viral Vectors and Plasmid DNA Manufacturing Product Portfolio Table 82. MassBiologics Recent Development Table 83. Richter-Helm Company Information Table 84. Richter-Helm Business Overview Table 85. Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Product Portfolio Table 87. Richter-Helm Recent Development Table 88. FUJIFILM Diosynth Biotechnologies Company Information Table 89. FUJIFILM Diosynth Biotechnologies Business Overview Table 90. FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Product Portfolio Table 92. FUJIFILM Diosynth Biotechnologies Recent Development Table 93. Lonza Company Information Table 94. Lonza Business Overview Table 95. Lonza Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Lonza Viral Vectors and Plasmid DNA Manufacturing Product Portfolio Table 97. Lonza Recent Development Table 98. Aldevron Company Information Table 99. Aldevron Business Overview Table 100. Aldevron Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Aldevron Viral Vectors and Plasmid DNA Manufacturing Product Portfolio Table 102. Aldevron Recent Development Table 103. Eurogentec Company Information Table 104. Eurogentec Business Overview Table 105. Eurogentec Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Eurogentec Viral Vectors and Plasmid DNA Manufacturing Product Portfolio Table 107. Eurogentec Recent Development Table 108. Cell and Gene Therapy Catapult Company Information Table 109. Cell and Gene Therapy Catapult Business Overview Table 110. Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Product Portfolio Table 112. Cell and Gene Therapy Catapult Recent Development Table 113. Biovian Company Information Table 114. Biovian Business Overview Table 115. Biovian Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Biovian Viral Vectors and Plasmid DNA Manufacturing Product Portfolio Table 117. Biovian Recent Development Table 118. Thermo Fisher Scientific (Brammer Bio) Company Information Table 119. Thermo Fisher Scientific (Brammer Bio) Business Overview Table 120. Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Product Portfolio Table 122. Thermo Fisher Scientific (Brammer Bio) Recent Development Table 123. VGXI Company Information Table 124. VGXI Business Overview Table 125. VGXI Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. VGXI Viral Vectors and Plasmid DNA Manufacturing Product Portfolio Table 127. VGXI Recent Development Table 128. PlasmidFactory Company Information Table 129. PlasmidFactory Business Overview Table 130. PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Product Portfolio Table 132. PlasmidFactory Recent Development Table 133. North America Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021-2026) Table 136. North America Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Viral Vectors and Plasmid DNA Manufacturing Market Share Forecast by Country (2027-2032) Table 138. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021-2026) Table 141. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Viral Vectors and Plasmid DNA Manufacturing Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021-2026) Table 146. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Share Forecast by Country (2027-2032) Table 148. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021-2026) Table 151. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Share Forecast by Country (2027-2032) Table 153. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021-2026) Table 156. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Share Forecast by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Viral Vectors and Plasmid DNA Manufacturing Product Image Figure 3. Global Viral Vectors and Plasmid DNA Manufacturing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million) Figure 5. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region: 2025 VS 2032 Figure 6. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2021-2032) Figure 7. North America Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Plasmid DNA Image Figure 13. Global Plasmid DNA Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Viral Vectors Image Figure 15. Global Viral Vectors Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Type 2025 VS 2032 Figure 18. North America Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Type (2021-2032) Figure 19. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Type (2021-2032) Figure 21. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Type (2021-2032) Figure 23. Cancers Image Figure 24. Global Cancers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Inherited Disorders Image Figure 26. Global Inherited Disorders Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Viral Infections Image Figure 28. Global Viral Infections Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Others Image Figure 30. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Application 2025 VS 2032 Figure 33. North America Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Application (2021-2032) Figure 34. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Application (2021-2032) Figure 36. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Viral Vectors and Plasmid DNA Manufacturing Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021-2032) Figure 43. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021-2032) Figure 46. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021-2032) Figure 49. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021-2032) Figure 52. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Plasmid DNA
  • Viral Vectors
Applications
  • Cancers
  • Inherited Disorders
  • Viral Infections
  • Others
Companies covered
  • BioReliance
  • Cobra Biologics
  • Oxford BioMedica
  • UniQure
  • FinVector
  • MolMed
  • MassBiologics
  • Richter-Helm
  • FUJIFILM Diosynth Biotechnologies
  • Lonza
  • Aldevron
  • Eurogentec
  • Cell and Gene Therapy Catapult
  • Biovian
  • Thermo Fisher Scientific (Brammer Bio)
  • VGXI
  • PlasmidFactory

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2021-2032)
  5. 1.4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2021-2026)
  6. 1.4.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2027-2032)
  7. 1.5 Key Regions Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032)
  8. 1.5.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate (2021-2032)
2 Viral Vectors and Plasmid DNA Manufacturing Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Plasmid DNA
  3. 2.1.2 Viral Vectors
  4. 2.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
  5. 2.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Regions
  9. 2.3.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Type (2021-2026)
3 Viral Vectors and Plasmid DNA Manufacturing Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Cancers
  3. 3.1.2 Inherited Disorders
  4. 3.1.3 Viral Infections
  5. 3.1.4 Others
  6. 3.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
  7. 3.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Regions
  11. 3.3.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Viral Vectors and Plasmid DNA Manufacturing Industry Trends
  2. 4.2 Viral Vectors and Plasmid DNA Manufacturing Industry Drivers
  3. 4.3 Viral Vectors and Plasmid DNA Manufacturing Industry Opportunities and Challenges
  4. 4.4 Viral Vectors and Plasmid DNA Manufacturing Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Viral Vectors and Plasmid DNA Manufacturing Revenue (2021-2026)
  2. 5.2 Global Viral Vectors and Plasmid DNA Manufacturing Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Viral Vectors and Plasmid DNA Manufacturing Key Company Headquarters & Area Served
  4. 5.4 Global Viral Vectors and Plasmid DNA Manufacturing Company, Product Type & Application
  5. 5.5 Global Viral Vectors and Plasmid DNA Manufacturing Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Viral Vectors and Plasmid DNA Manufacturing Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Viral Vectors and Plasmid DNA Manufacturing Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Viral Vectors and Plasmid DNA Manufacturing Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 BioReliance
  2. 6.1.1 BioReliance Company Information
  3. 6.1.2 BioReliance Business Overview
  4. 6.1.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 BioReliance Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
  6. 6.1.5 BioReliance Recent Developments
  7. 6.2 Cobra Biologics
  8. 6.2.1 Cobra Biologics Company Information
  9. 6.2.2 Cobra Biologics Business Overview
  10. 6.2.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
  12. 6.2.5 Cobra Biologics Recent Developments
  13. 6.3 Oxford BioMedica
  14. 6.3.1 Oxford BioMedica Company Information
  15. 6.3.2 Oxford BioMedica Business Overview
  16. 6.3.3 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
  18. 6.3.5 Oxford BioMedica Recent Developments
  19. 6.4 UniQure
  20. 6.4.1 UniQure Company Information
  21. 6.4.2 UniQure Business Overview
  22. 6.4.3 UniQure Viral Vectors and Plasmid DNA Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 UniQure Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
  24. 6.4.5 UniQure Recent Developments
  25. 6.5 FinVector
  26. 6.5.1 FinVector Company Information
  27. 6.5.2 FinVector Business Overview
  28. 6.5.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 FinVector Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
  30. 6.5.5 FinVector Recent Developments
  31. 6.6 MolMed
  32. 6.6.1 MolMed Company Information
  33. 6.6.2 MolMed Business Overview
  34. 6.6.3 MolMed Viral Vectors and Plasmid DNA Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 MolMed Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
  36. 6.6.5 MolMed Recent Developments
  37. 6.7 MassBiologics
  38. 6.7.1 MassBiologics Company Information
  39. 6.7.2 MassBiologics Business Overview
  40. 6.7.3 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
  42. 6.7.5 MassBiologics Recent Developments
  43. 6.8 Richter-Helm
  44. 6.8.1 Richter-Helm Company Information
  45. 6.8.2 Richter-Helm Business Overview
  46. 6.8.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
  48. 6.8.5 Richter-Helm Recent Developments
  49. 6.9 FUJIFILM Diosynth Biotechnologies
  50. 6.9.1 FUJIFILM Diosynth Biotechnologies Company Information
  51. 6.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
  52. 6.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
  54. 6.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments
  55. 6.10 Lonza
  56. 6.10.1 Lonza Company Information
  57. 6.10.2 Lonza Business Overview
  58. 6.10.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Lonza Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
  60. 6.10.5 Lonza Recent Developments
  61. 6.11 Aldevron
  62. 6.11.1 Aldevron Company Information
  63. 6.11.2 Aldevron Business Overview
  64. 6.11.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Aldevron Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
  66. 6.11.5 Aldevron Recent Developments
  67. 6.12 Eurogentec
  68. 6.12.1 Eurogentec Company Information
  69. 6.12.2 Eurogentec Business Overview
  70. 6.12.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
  72. 6.12.5 Eurogentec Recent Developments
  73. 6.13 Cell and Gene Therapy Catapult
  74. 6.13.1 Cell and Gene Therapy Catapult Company Information
  75. 6.13.2 Cell and Gene Therapy Catapult Business Overview
  76. 6.13.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
  78. 6.13.5 Cell and Gene Therapy Catapult Recent Developments
  79. 6.14 Biovian
  80. 6.14.1 Biovian Company Information
  81. 6.14.2 Biovian Business Overview
  82. 6.14.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Biovian Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
  84. 6.14.5 Biovian Recent Developments
  85. 6.15 Thermo Fisher Scientific (Brammer Bio)
  86. 6.15.1 Thermo Fisher Scientific (Brammer Bio) Company Information
  87. 6.15.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
  88. 6.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
  90. 6.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Developments
  91. 6.16 VGXI
  92. 6.16.1 VGXI Company Information
  93. 6.16.2 VGXI Business Overview
  94. 6.16.3 VGXI Viral Vectors and Plasmid DNA Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 VGXI Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
  96. 6.16.5 VGXI Recent Developments
  97. 6.17 PlasmidFactory
  98. 6.17.1 PlasmidFactory Company Information
  99. 6.17.2 PlasmidFactory Business Overview
  100. 6.17.3 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
  102. 6.17.5 PlasmidFactory Recent Developments
7 North America
  1. 7.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021-2026)
  3. 7.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021-2026)
  3. 8.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021-2026)
  3. 10.3 South America Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst